Q9Y6E0 (STK24_HUMAN) Homo sapiens (Human)
Serine/threonine-protein kinase 24 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of MST3-MO25 complex with WIF motif |
Heteromer Q9Y376; | 1×ADP; 1×MN; | ||||
| Assess | ||||||
| Human MST3 (STK24) in complex with MO25beta |
Heteromer Q9H9S4; | 2×SO4; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with inhibitor MR24 | homo-2-mer | 2×VYN; 3×EDO; | ||||
| Assess | ||||||
| Human MST3 kinase | monomer | |||||
| Assess | ||||||
| MST3 in complex with CP-673451 | monomer | 1×34U; 1×EDO; 1×PEG; | ||||
| Assess | ||||||
| Human MST3 kinase in complex with ATP | monomer | 1×ATP; | ||||
| Assess | ||||||
| Human MST3 kinase | monomer | |||||
| Assess | ||||||
| MST3 IN COMPLEX WITH CDK1/2 INHIBITOR III, 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUO… | monomer | 1×EDO; 1×DKI; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH AT-9283, 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZ… | monomer | 1×35R; 2×ACT; 2×EDO; 1×CL; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH Imidazolo-oxindole PKR inhibitor C16 | monomer | 1×EDO; 1×34L; 1×PG4; 1×DMS; 1×CL; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH PF-03814735, N-{2-[(1S,4R)-6-{[4-(CYCLOBUTYLAMINO)-5-(TRIFLUOROMETHYL)PYRIMIDI… | monomer | 1×34W; 2×EDO; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH STAUROSPORINE | monomer | 1×STU; 1×CL; 1×EDO; | ||||
| Assess | ||||||
| Structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06645342) | monomer | 1×3JB; | ||||
| Assess | ||||||
| MST3 in complex with SARACATINIB | monomer | 1×H8H; | ||||
| Assess | ||||||
| Human MST3 kinase in complex with adenine | monomer | 1×ADE; | ||||
| Assess | ||||||
| Human MST3 kinase in complex with MnADP | monomer | 1×ADP; 2×MN; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH JNJ-7706621, 4-({5-AMINO-1-[(2,6-DIFLUOROPHENYL)CARBONYL]-1H-1,2,4-TRIAZOL-3-Y… | monomer | 1×SKE; 1×MG; 1×DMS; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH PP-121, 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRI… | monomer | 1×KS1; 1×EDO; 1×ACT; | ||||
| Assess | ||||||
| Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06447475) | monomer | 1×MN; 1×3FE; | ||||
| Assess | ||||||
| Crystal structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06454589). | monomer | 1×3JA; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH SUNITINIB | monomer | 1×B49; 2×CL; | ||||
| Assess | ||||||
| MST3 in complex with HESPERADIN | monomer | 1×H1N; 1×EDO; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH 2-(4,6-Diamino-1,3,5-triazin-2-yl)phenol | monomer | 1×X11; | ||||
| Assess | ||||||
| MST3 in complex with DASATINIB | monomer | 1×1N1; 1×EDO; 1×CL; | ||||
| Assess | ||||||
| MST3 in complex with BOSUTINIB | monomer | 1×DB8; | ||||
| Assess | ||||||
| MST3 in complex with AMP-PNP | monomer | 1×EDO; 1×MG; 1×ANP; | ||||
| Assess | ||||||
| MST3 IN COMPLEX WITH Danusertib | monomer | 1×PGE; 1×EDO; 1×CL; 1×627; | ||||
| Assess | ||||||
| Crystal structure of sterile 20-like kinase 3 (MST3, STK24) | monomer | 2×HG; | ||||
| Assess | ||||||
| Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine | monomer | 1×STU; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with inhibitor MR30 | monomer | 1×VZ2; 3×EDO; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with inhibitor MR26 | monomer | 1×VYH; 11×EDO; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310 | monomer | 1×VY0; 1×EDO; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with inhibitor MR39 | monomer | 1×SJL; 3×EDO; | ||||
| Assess | ||||||
| MST3 in complex with MRIA7 | monomer | 1×SQQ; | ||||
| Assess | ||||||
| MST3 in complex with compound MRIA9 | monomer | 1×SQ8; | ||||
| Assess | ||||||
| MST3 in complex with MRIA11 | monomer | 4×EDO; 1×SQE; | ||||
| Assess | ||||||
| MST3 in complex with compound G-5555 | monomer | 1×59T; | ||||
| Assess | ||||||
| MST3 in complex with compound MRIA12 | monomer | 7×EDO; 1×SQK; | ||||
| Assess | ||||||
| MST3 in complex with compound MRIA13 | monomer | 1×SQB; | ||||
| Assess | ||||||
| Human MST3 (STK24) kinase in complex with inhibitor MRLW5 | monomer | 1×SJX; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4qmt.1.A | monomer | 0.86 | 1×H1N; | 99.65 | ||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 3a7g.2.A | monomer | 0.85 | 100.00 | ||
| Assess | ||||||